id	sid	eid	entity	type
ihlr-16500	2	1	neil f. hazaray•	PERSON
ihlr-16500	2	2	i. introduction	PERSON
ihlr-16500	2	3	116 ii	QUANTITY
ihlr-16500	2	4	•	CARDINAL
ihlr-16500	2	5	••••.••••••..•••••	PERSON
ihlr-16500	2	6	••••••	CARDINAL
ihlr-16500	2	7	•••. 117 a.	PERSON
ihlr-16500	2	8	•.....................•	CARDINAL
ihlr-16500	2	9	•	CARDINAL
ihlr-16500	2	10	117	CARDINAL
ihlr-16500	2	11	118	CARDINAL
ihlr-16500	3	1	118 1	CARDINAL
ihlr-16500	4	1	119 2	CARDINAL
ihlr-16500	5	1	120 3	CARDINAL
ihlr-16500	6	1	121 iii	QUANTITY
ihlr-16500	7	1	fda	ORG
ihlr-16500	7	2	122	CARDINAL
ihlr-16500	9	1	125	CARDINAL
ihlr-16500	9	2	a. vioxx	PERSON
ihlr-16500	9	3	merck	ORG
ihlr-16500	9	4	126	CARDINAL
ihlr-16500	9	5	130	CARDINAL
ihlr-16500	9	6	132	CARDINAL
ihlr-16500	10	1	135	CARDINAL
ihlr-16500	10	2	136	CARDINAL
ihlr-16500	10	3	139	CARDINAL
ihlr-16500	10	4	141	CARDINAL
ihlr-16500	11	1	141	CARDINAL
ihlr-16500	13	1	142 b.	PERSON
ihlr-16500	13	2	fda	ORG
ihlr-16500	15	1	143	CARDINAL
ihlr-16500	15	2	116	CARDINAL
ihlr-16500	15	3	indiana health law review	ORG
ihlr-16500	16	1	4:115	CARDINAL
ihlr-16500	18	1	144	CARDINAL
ihlr-16500	18	2	d.	NORP
ihlr-16500	19	1	145	CARDINAL
ihlr-16500	20	1	145	CARDINAL
ihlr-16500	21	1	147	CARDINAL
ihlr-16500	22	1	14 7	DATE
ihlr-16500	25	1	today	DATE
ihlr-16500	26	1	recent years	DATE
ihlr-16500	28	1	first	ORDINAL
ihlr-16500	30	1	the united states	GPE
ihlr-16500	32	1	merck	ORG
ihlr-16500	32	2	glaxosmithkline	PERSON
ihlr-16500	34	1	2007	DATE
ihlr-16500	34	2	indiana university school of law	ORG
ihlr-16500	34	3	indianapolis	GPE
ihlr-16500	34	4	indiana	GPE
ihlr-16500	34	5	2007	DATE
ihlr-16500	34	6	indiana university	ORG
ihlr-16500	34	7	kelley school of business	ORG
ihlr-16500	34	8	indianapolis	GPE
ihlr-16500	34	9	indiana	GPE
ihlr-16500	34	10	b.s.	GPE
ihlr-16500	34	11	2002	DATE
ihlr-16500	34	12	indiana university	ORG
ihlr-16500	34	13	bloomington	GPE
ihlr-16500	34	14	indiana	GPE
ihlr-16500	35	1	sean	NORP
ihlr-16500	37	1	david jose	PERSON
ihlr-16500	38	1	1	CARDINAL
ihlr-16500	38	2	yahoo	ORG
ihlr-16500	38	3	feb. 15, 2007	DATE
ihlr-16500	39	1	merck	ORG
ihlr-16500	39	2	glaxosmithkline	ORG
ihlr-16500	39	3	the new york stock ex­	ORG
ihlr-16500	41	1	2007	DATE
ihlr-16500	42	1	117	CARDINAL
ihlr-16500	49	1	the united states	GPE
ihlr-16500	49	2	fda	ORG
ihlr-16500	52	1	part vi	PERSON
ihlr-16500	54	1	u.s.	GPE
ihlr-16500	56	1	the united states	GPE
ihlr-16500	57	1	more than one billion dollars	MONEY
ihlr-16500	57	2	2003	DATE
ihlr-16500	57	3	phar2	PERSON
ihlr-16500	57	4	118	CARDINAL
ihlr-16500	57	5	indiana	GPE
ihlr-16500	58	1	4:115	CARDINAL
ihlr-16500	58	2	sixty-seven	CARDINAL
ihlr-16500	58	3	over $136	MONEY
ihlr-16500	58	4	between 2004 and 2009	DATE
ihlr-16500	58	5	at least twenty-four	CARDINAL
ihlr-16500	59	1	the second quarter of2006	DATE
ihlr-16500	59	2	of$2.86 billion	MONEY
ihlr-16500	60	1	5	CARDINAL
ihlr-16500	62	1	of2005	NORP
ihlr-16500	62	2	of$16.99 billion	CARDINAL
ihlr-16500	62	3	u.s.	GPE
ihlr-16500	63	1	6	CARDINAL
ihlr-16500	67	1	fda	ORG
ihlr-16500	69	1	fda	ORG
ihlr-16500	70	1	note7	FAC
ihlr-16500	72	1	the united states	GPE
ihlr-16500	73	1	2003 to 2004	DATE
ihlr-16500	73	2	2004	DATE
ihlr-16500	74	1	1 088&adselection	CARDINAL
ihlr-16500	74	2	y &industryldll =-1	ORG
ihlr-16500	75	1	3	CARDINAL
ihlr-16500	76	1	5	CARDINAL
ihlr-16500	76	2	juliann walsh &	ORG
ihlr-16500	76	3	nicole ostrow	PERSON
ihlr-16500	76	4	merck	ORG
ihlr-16500	76	5	bloomberg.com	ORG
ihlr-16500	76	6	july 21, 2004	DATE
ihlr-16500	77	1	al u3vuxkojwe&refer=	PERSON
ihlr-16500	77	2	6	CARDINAL
ihlr-16500	77	3	26, 2006	DATE
ihlr-16500	77	4	2007	DATE
ihlr-16500	77	5	119 8.3%	PERCENT
ihlr-16500	78	1	8	CARDINAL
ihlr-16500	78	2	every year	DATE
ihlr-16500	79	1	twenty	CARDINAL
ihlr-16500	79	2	approximately $2.5 billion	MONEY
ihlr-16500	79	3	$235 billion	MONEY
ihlr-16500	79	4	2004	DATE
ihlr-16500	79	5	nearly nineteen billion dollars	MONEY
ihlr-16500	80	1	11	CARDINAL
ihlr-16500	81	1	nearly one	CARDINAL
ihlr-16500	81	2	ten dollars	MONEY
ihlr-16500	81	3	nearly fourteen percent	PERCENT
ihlr-16500	81	4	2010.12 1	CARDINAL
ihlr-16500	83	1	8 2004 year-end	DATE
ihlr-16500	83	2	u.s.	GPE
ihlr-16500	83	3	imshealtilcom	ORG
ihlr-16500	83	4	feb. 22, 2006	DATE
ihlr-16500	83	5	http://www.imshealth.com/ims/portallfront/articlec/0,2777	ORG
ihlr-16500	83	6	6599	DATE
ihlr-16500	85	1	2004 year-end	DATE
ihlr-16500	86	1	9	CARDINAL
ihlr-16500	86	2	20	CARDINAL
ihlr-16500	86	3	u.s.	GPE
ihlr-16500	86	4	2005	DATE
ihlr-16500	86	5	73914140_77266121	CARDINAL
ihlr-16500	87	1	10 2004 year-end	DATE
ihlr-16500	87	2	8	CARDINAL
ihlr-16500	89	1	hmo	ORG
ihlr-16500	90	1	11	CARDINAL
ihlr-16500	91	1	2005	DATE
ihlr-16500	91	2	of$51.3 billion	MONEY
ihlr-16500	92	1	america	GPE
ihlr-16500	92	2	2006 10 (2006	DATE
ihlr-16500	93	1	2006	DATE
ihlr-16500	93	2	12	CARDINAL
ihlr-16500	93	3	800	MONEY
ihlr-16500	93	4	232	CARDINAL
ihlr-16500	93	5	2004	DATE
ihlr-16500	94	1	13	CARDINAL
ihlr-16500	95	1	14	CARDINAL
ihlr-16500	95	2	http://www.medicinenet.com/statins/article.htm	DATE
ihlr-16500	95	3	feb. 15, 2007	DATE
ihlr-16500	98	1	•	CARDINAL
ihlr-16500	99	1	zocor	ORG
ihlr-16500	99	2	three	CARDINAL
ihlr-16500	100	1	2004 year-end	DATE
ihlr-16500	100	2	8	CARDINAL
ihlr-16500	101	1	120	CARDINAL
ihlr-16500	101	2	indiana health law review	ORG
ihlr-16500	102	1	4:115	CARDINAL
ihlr-16500	102	2	money.18	PRODUCT
ihlr-16500	104	1	2	CARDINAL
ihlr-16500	106	1	19	CARDINAL
ihlr-16500	106	2	2004	DATE
ihlr-16500	106	3	ten	CARDINAL
ihlr-16500	106	4	nearly thirty-eight billion dollars	CARDINAL
ihlr-16500	107	1	20	CARDINAL
ihlr-16500	107	2	2004	DATE
ihlr-16500	107	3	ten	CARDINAL
ihlr-16500	107	4	the united states	GPE
ihlr-16500	107	5	more than two billion dollars	MONEY
ihlr-16500	107	6	$7.7 billion	MONEY
ihlr-16500	108	1	22	CARDINAL
ihlr-16500	109	1	millions	CARDINAL
ihlr-16500	109	2	billions	CARDINAL
ihlr-16500	110	1	15	CARDINAL
ihlr-16500	110	2	merrill matthews	ORG
ihlr-16500	110	3	jr.	PERSON
ihlr-16500	110	4	july 1, 2001	DATE
ihlr-16500	111	1	16	CARDINAL
ihlr-16500	111	2	12	CARDINAL
ihlr-16500	111	3	229	CARDINAL
ihlr-16500	112	1	17	CARDINAL
ihlr-16500	112	2	14	CARDINAL
ihlr-16500	115	1	jd	PERSON
ihlr-16500	117	1	jd	PERSON
ihlr-16500	119	1	jd	PERSON
ihlr-16500	119	2	18	CARDINAL
ihlr-16500	119	3	walsh & ostrow	ORG
ihlr-16500	119	4	supra	PERSON
ihlr-16500	119	5	5	CARDINAL
ihlr-16500	119	6	19	CARDINAL
ihlr-16500	119	7	catherine arnst et al.	PERSON
ihlr-16500	120	1	online	PERSON
ihlr-16500	120	2	oct. 18, 2004	DATE
ihlr-16500	123	1	20 2004 year-end	DATE
ihlr-16500	123	2	8	CARDINAL
ihlr-16500	124	1	22	CARDINAL
ihlr-16500	125	1	one billion dollars	MONEY
ihlr-16500	126	1	2007	DATE
ihlr-16500	127	1	121	CARDINAL
ihlr-16500	128	1	first	ORDINAL
ihlr-16500	130	1	5.4%	PERCENT
ihlr-16500	130	2	2005,23	CARDINAL
ihlr-16500	130	3	8.3%	PERCENT
ihlr-16500	130	4	2004.24	CARDINAL
ihlr-16500	130	5	bextra	ORG
ihlr-16500	130	6	drug26	ORG
ihlr-16500	130	7	expiration27	PERSON
ihlr-16500	131	1	3	CARDINAL
ihlr-16500	131	2	the years	DATE
ihlr-16500	131	3	the united states'	GPE
ihlr-16500	132	1	28	CARDINAL
ihlr-16500	133	1	the united states'	GPE
ihlr-16500	133	2	18.2 years	DATE
ihlr-16500	133	3	30	CARDINAL
ihlr-16500	135	1	23	CARDINAL
ihlr-16500	135	2	5.4 percent	PERCENT
ihlr-16500	135	3	2005	DATE
ihlr-16500	135	4	u.s.	GPE
ihlr-16500	135	5	imsheal11i.com	ORG
ihlr-16500	135	6	feb. 22, 2006	DATE
ihlr-16500	135	7	http://www.imshealth.com/ims/portallfron11articlec/0,2777	ORG
ihlr-16500	135	8	6599	DATE
ihlr-16500	139	1	24 2004 year-end	DATE
ihlr-16500	139	2	8. 25 percent	PERCENT
ihlr-16500	139	3	23	CARDINAL
ihlr-16500	139	4	26	CARDINAL
ihlr-16500	141	1	314.108	CARDINAL
ihlr-16500	141	2	2006	DATE
ihlr-16500	142	1	27	CARDINAL
ihlr-16500	142	2	twenty years	DATE
ihlr-16500	144	1	feb. 15, 2007	DATE
ihlr-16500	145	1	28	CARDINAL
ihlr-16500	146	1	u.s.	GPE
ihlr-16500	146	2	til & human	ORG
ihlr-16500	146	3	americans	NORP
ihlr-16500	146	4	2004	DATE
ihlr-16500	146	5	2004	DATE
ihlr-16500	146	6	http://www.aoa.gov/prof/statistics/ profile/2004/2004profile	PRODUCT
ihlr-16500	146	7	29 /d	PERCENT
ihlr-16500	147	1	2003	DATE
ihlr-16500	147	2	over two million	CARDINAL
ihlr-16500	147	3	sixty-five	CARDINAL
ihlr-16500	148	1	d.	NORP
ihlr-16500	148	2	1.8 million	CARDINAL
ihlr-16500	148	3	age sixty-five	DATE
ihlr-16500	148	4	over 317,000	CARDINAL
ihlr-16500	150	1	3q	CARDINAL
ihlr-16500	151	1	122	CARDINAL
ihlr-16500	151	2	indiana health law review	ORG
ihlr-16500	152	1	4:115	CARDINAL
ihlr-16500	155	1	fda	ORG
ihlr-16500	158	1	only five percent	PERCENT
ihlr-16500	158	2	two	CARDINAL
ihlr-16500	158	3	three	CARDINAL
ihlr-16500	158	4	ten percent	PERCENT
ihlr-16500	159	1	31	CARDINAL
ihlr-16500	160	1	hundreds of millions of dollars	MONEY
ihlr-16500	160	2	the pharmaceuti­ cal industry	ORG
ihlr-16500	161	1	seventeen	CARDINAL
ihlr-16500	161	2	1995	DATE
ihlr-16500	161	3	sixty-seven	CARDINAL
ihlr-16500	161	4	2003.32	CARDINAL
ihlr-16500	162	1	fda	ORG
ihlr-16500	163	1	33	CARDINAL
ihlr-16500	163	2	dic­	ORG
ihlr-16500	165	1	fda	ORG
ihlr-16500	166	1	34	CARDINAL
ihlr-16500	166	2	fda	ORG
ihlr-16500	166	3	35	CARDINAL
ihlr-16500	166	4	fda	ORG
ihlr-16500	166	5	develop31	GPE
ihlr-16500	167	1	feb. 2005	DATE
ihlr-16500	168	1	32	CARDINAL
ihlr-16500	168	2	93%to $262 billion	MONEY
ihlr-16500	168	3	2009	CARDINAL
ihlr-16500	168	4	nov. 15,2004	DATE
ihlr-16500	168	5	http://www.pr9.net/health/medicine/1322	GPE
ihlr-16500	168	6	ber.html	ORG
ihlr-16500	169	1	33	CARDINAL
ihlr-16500	169	2	christopher placitella	PERSON
ihlr-16500	169	3	justin klein	PERSON
ihlr-16500	169	4	43	CARDINAL
ihlr-16500	170	1	l. rev	PERSON
ihlr-16500	170	2	219	CARDINAL
ihlr-16500	170	3	220	CARDINAL
ihlr-16500	170	4	2005	DATE
ihlr-16500	171	1	34	CARDINAL
ihlr-16500	171	2	1998	DATE
ihlr-16500	171	3	http://www.fda	DATE
ihlr-16500	173	1	fda	ORG
ihlr-16500	173	2	2007	DATE
ihlr-16500	173	3	123	CARDINAL
ihlr-16500	175	1	37	CARDINAL
ihlr-16500	175	2	three	CARDINAL
ihlr-16500	176	1	first	ORDINAL
ihlr-16500	177	1	38	CARDINAL
ihlr-16500	178	1	39	CARDINAL
ihlr-16500	179	1	40	CARDINAL
ihlr-16500	179	2	second	ORDINAL
ihlr-16500	180	1	41	CARDINAL
ihlr-16500	180	2	third	ORDINAL
ihlr-16500	181	1	42	CARDINAL
ihlr-16500	181	2	fda	ORG
ihlr-16500	181	3	fda	ORG
ihlr-16500	181	4	manpower.44	ORG
ihlr-16500	181	5	congress	ORG
ihlr-16500	181	6	nearly fifteen years	DATE
ihlr-16500	181	7	fda	ORG
ihlr-16500	181	8	fda	ORG
ihlr-16500	181	9	six	CARDINAL
ihlr-16500	181	10	twelve	CARDINAL
ihlr-16500	181	11	months.46	NORP
ihlr-16500	181	12	1992	DATE
ihlr-16500	186	1	feb. 16, 2007	DATE
ihlr-16500	190	1	38	CARDINAL
ihlr-16500	190	2	144	CARDINAL
ihlr-16500	190	3	2004	DATE
ihlr-16500	190	4	food& drug admin.	ORG
ihlr-16500	190	5	supra	PERSON
ihlr-16500	190	6	34	CARDINAL
ihlr-16500	190	7	39	CARDINAL
ihlr-16500	190	8	food & drug admin	ORG
ihlr-16500	190	9	supra	PERSON
ihlr-16500	190	10	34	CARDINAL
ihlr-16500	191	1	41 ng	QUANTITY
ihlr-16500	191	2	38	CARDINAL
ihlr-16500	191	3	145	CARDINAL
ihlr-16500	191	4	food &drug admin.	ORG
ihlr-16500	191	5	supra	PERSON
ihlr-16500	191	6	34	CARDINAL
ihlr-16500	191	7	42 ng	QUANTITY
ihlr-16500	191	8	38	CARDINAL
ihlr-16500	191	9	146	CARDINAL
ihlr-16500	191	10	food & drug admin.	ORG
ihlr-16500	191	11	supra	PERSON
ihlr-16500	192	1	34	CARDINAL
ihlr-16500	193	1	43	CARDINAL
ihlr-16500	193	2	deborah g. parver	PERSON
ihlr-16500	193	3	fda	ORG
ihlr-16500	193	4	1997	DATE
ihlr-16500	193	5	51	CARDINAL
ihlr-16500	194	1	l. rev	PERSON
ihlr-16500	194	2	1249	CARDINAL
ihlr-16500	194	3	1249-53	CARDINAL
ihlr-16500	194	4	1999	DATE
ihlr-16500	195	1	44	DATE
ihlr-16500	195	2	1255	CARDINAL
ihlr-16500	196	1	45	CARDINAL
ihlr-16500	196	2	1253	DATE
ihlr-16500	196	3	1255	CARDINAL
ihlr-16500	197	1	46 ng	QUANTITY
ihlr-16500	197	2	38	DATE
ihlr-16500	197	3	forty-two days	DATE
ihlr-16500	198	1	124	CARDINAL
ihlr-16500	198	2	indiana health law review	ORG
ihlr-16500	198	3	4:115	CARDINAL
ihlr-16500	200	1	drug with­	ORG
ihlr-16500	200	2	recent years	DATE
ihlr-16500	201	1	market.48	PERSON
ihlr-16500	202	1	over $800 million dollars	MONEY
ihlr-16500	203	1	5°	CARDINAL
ihlr-16500	203	2	five to ten thousand	CARDINAL
ihlr-16500	203	3	fda	ORG
ihlr-16500	203	4	only one	CARDINAL
ihlr-16500	204	1	51	CARDINAL
ihlr-16500	205	1	fda	ORG
ihlr-16500	206	1	2004	DATE
ihlr-16500	206	2	senate finance committee	ORG
ihlr-16500	206	3	david graham	PERSON
ihlr-16500	206	4	di­	PERSON
ihlr-16500	206	5	fda	ORG
ihlr-16500	206	6	fda	ORG
ihlr-16500	206	7	american	NORP
ihlr-16500	206	8	fda	ORG
ihlr-16500	206	9	47	DATE
ihlr-16500	206	10	ctr	GPE
ihlr-16500	207	1	u.s. food & drug admin	ORG
ihlr-16500	207	2	2005	DATE
ihlr-16500	207	3	http://www.fda.gov/cder/news/pdufagoals.htm	LOC
ihlr-16500	208	1	fda	ORG
ihlr-16500	209	1	only seven years	DATE
ihlr-16500	211	1	48	CARDINAL
ihlr-16500	211	2	2006	DATE
ihlr-16500	211	3	49	DATE
ihlr-16500	211	4	marcia angell	PERSON
ihlr-16500	211	5	n.y.	GPE
ihlr-16500	211	6	bks.	GPE
ihlr-16500	211	7	july 15, 2004	DATE
ihlr-16500	213	1	50	CARDINAL
ihlr-16500	213	2	2006	DATE
ihlr-16500	213	3	11	CARDINAL
ihlr-16500	213	4	contra angell	PERSON
ihlr-16500	213	5	supra	PERSON
ihlr-16500	213	6	49	DATE
ihlr-16500	214	1	st j. michael hayes	PERSON
ihlr-16500	214	2	the united states	GPE
ihlr-16500	214	3	3	CARDINAL
ihlr-16500	215	1	1141768340&t=	CARDINAL
ihlr-16500	215	2	feb. 16, 2007	DATE
ihlr-16500	218	1	one	CARDINAL
ihlr-16500	219	1	52	CARDINAL
ihlr-16500	219	2	placitella & klein	ORG
ihlr-16500	219	3	supra	PERSON
ihlr-16500	219	4	33	CARDINAL
ihlr-16500	219	5	2007	DATE
ihlr-16500	220	1	125	CARDINAL
ihlr-16500	220	2	drugs.53	ORG
ihlr-16500	220	3	the american medical association	ORG
ihlr-16500	220	4	graham	PERSON
ihlr-16500	220	5	fda	ORG
ihlr-16500	221	1	thousands	CARDINAL
ihlr-16500	221	2	each year	DATE
ihlr-16500	221	3	first	ORDINAL
ihlr-16500	222	1	54	CARDINAL
ihlr-16500	222	2	fda	ORG
ihlr-16500	223	1	third	ORDINAL
ihlr-16500	224	1	third	ORDINAL
ihlr-16500	226	1	third	ORDINAL
ihlr-16500	227	1	recent years	DATE
ihlr-16500	229	1	fda	ORG
ihlr-16500	230	1	fda	ORG
ihlr-16500	231	1	fda	ORG
ihlr-16500	232	1	fda	ORG
ihlr-16500	234	1	recent years	DATE
ihlr-16500	235	1	55	CARDINAL
ihlr-16500	236	1	220	CARDINAL
ihlr-16500	238	1	221	CARDINAL
ihlr-16500	239	1	55	CARDINAL
ihlr-16500	239	2	parke-davis	ORG
ihlr-16500	239	3	warner-lambert inc.	ORG
ihlr-16500	239	4	u.s.	GPE
ihlr-16500	239	5	2000	DATE
ihlr-16500	240	1	jim morris	PERSON
ihlr-16500	240	2	126	CARDINAL
ihlr-16500	240	3	indiana health law review	ORG
ihlr-16500	241	1	4:115	CARDINAL
ihlr-16500	242	1	56	CARDINAL
ihlr-16500	243	1	57	CARDINAL
ihlr-16500	244	1	cur­	NORP
ihlr-16500	246	1	first	ORDINAL
ihlr-16500	249	1	58	CARDINAL
ihlr-16500	252	1	second	ORDINAL
ihlr-16500	255	1	fda	ORG
ihlr-16500	256	1	a. vioxx	PERSON
ihlr-16500	256	2	merck	ORG
ihlr-16500	256	3	2004	DATE
ihlr-16500	256	4	united states	GPE
ihlr-16500	257	1	59	CARDINAL
ihlr-16500	257	2	merck	ORG
ihlr-16500	257	3	63	CARDINAL
ihlr-16500	257	4	mar. 23, 2000	DATE
ihlr-16500	258	1	bayer	ORG
ihlr-16500	258	2	2001	DATE
ihlr-16500	259	1	david brown	PERSON
ihlr-16500	260	1	aug. 9, 2001	DATE
ihlr-16500	260	2	aol	ORG
ihlr-16500	261	1	56	CARDINAL
ihlr-16500	262	1	57	CARDINAL
ihlr-16500	262	2	bayer	ORG
ihlr-16500	263	1	58	CARDINAL
ihlr-16500	263	2	november	DATE
ihlr-16500	263	3	200	CARDINAL
ihlr-16500	263	4	tap pharmaceuticals inc	ORG
ihlr-16500	263	5	of$875 million	CARDINAL
ihlr-16500	264	1	judith a. waltz	PERSON
ihlr-16500	264	2	multimillion dollar	MONEY
ihlr-16500	264	3	nov. 2001	DATE
ihlr-16500	264	4	15	CARDINAL
ihlr-16500	264	5	1	CARDINAL
ihlr-16500	264	6	59	CARDINAL
ihlr-16500	264	7	sept 30, 2004	DATE
ihlr-16500	264	8	127	CARDINAL
ihlr-16500	264	9	fifty	CARDINAL
ihlr-16500	265	1	61	CARDINAL
ihlr-16500	265	2	fda	ORG
ihlr-16500	265	3	merck	ORG
ihlr-16500	265	4	fda	ORG
ihlr-16500	265	5	the next few weeks	DATE
ihlr-16500	265	6	months	DATE
ihlr-16500	267	1	the united states	GPE
ihlr-16500	267	2	4,300	CARDINAL
ihlr-16500	267	3	merck	ORG
ihlr-16500	268	1	63	CARDINAL
ihlr-16500	269	1	first	ORDINAL
ihlr-16500	269	2	tical companies	ORG
ihlr-16500	270	1	64	CARDINAL
ihlr-16500	270	2	second	ORDINAL
ihlr-16500	271	1	65	CARDINAL
ihlr-16500	271	2	lawsuits.66	NORP
ihlr-16500	272	1	2005	DATE
ihlr-16500	272	2	three	CARDINAL
ihlr-16500	272	3	30vioxx.htm	CARDINAL
ihlr-16500	273	1	vioxx	PERSON
ihlr-16500	277	1	60	CARDINAL
ihlr-16500	278	1	6	CARDINAL
ihlr-16500	280	1	fda	ORG
ihlr-16500	280	2	dr.	PERSON
ihlr-16500	280	3	lester m. crawford	PERSON
ihlr-16500	281	1	63	CARDINAL
ihlr-16500	281	2	anthony j. sebok	PERSON
ihlr-16500	281	3	what'snextfor	DATE
ihlr-16500	282	1	aug. 23, 2005	DATE
ihlr-16500	282	2	http://www .cnn.com/2005	ORG
ihlr-16500	284	1	64	CARDINAL
ihlr-16500	284	2	supra	PERSON
ihlr-16500	284	3	63	CARDINAL
ihlr-16500	284	4	jerry avorn	PERSON
ihlr-16500	284	5	371	CARDINAL
ihlr-16500	284	6	2004	DATE
ihlr-16500	285	1	65	CARDINAL
ihlr-16500	285	2	supra	PERSON
ihlr-16500	285	3	63	CARDINAL
ihlr-16500	286	1	66	CARDINAL
ihlr-16500	289	1	d.	NORP
ihlr-16500	291	1	128	CARDINAL
ihlr-16500	291	2	indiana health law review	ORG
ihlr-16500	292	1	4:115	CARDINAL
ihlr-16500	295	1	first	ORDINAL
ihlr-16500	295	2	texas	GPE
ihlr-16500	295	3	several months	DATE
ihlr-16500	295	4	vi­ oxx	PERSON
ihlr-16500	295	5	de­	GPE
ihlr-16500	296	1	69	CARDINAL
ihlr-16500	297	1	$253 million	MONEY
ihlr-16500	297	2	$229 million	MONEY
ihlr-16500	297	3	dam­ ages	GPE
ihlr-16500	298	1	70	CARDINAL
ihlr-16500	301	1	first	ORDINAL
ihlr-16500	301	2	u.s.	GPE
ihlr-16500	301	3	hundreds	CARDINAL
ihlr-16500	301	4	merck	ORG
ihlr-16500	302	1	second	ORDINAL
ihlr-16500	303	1	third	ORDINAL
ihlr-16500	303	2	merck	ORG
ihlr-16500	303	3	first	ORDINAL
ihlr-16500	303	4	thousands	CARDINAL
ihlr-16500	305	1	second	ORDINAL
ihlr-16500	305	2	new jersey	GPE
ihlr-16500	305	3	humeston v. merck/2	PERSON
ihlr-16500	305	4	merck	ORG
ihlr-16500	308	1	73	CARDINAL
ihlr-16500	309	1	new jersey	GPE
ihlr-16500	309	2	loca68	ORG
ihlr-16500	309	3	texas	GPE
ihlr-16500	309	4	$250 million	MONEY
ihlr-16500	309	5	jm vioxx	ORG
ihlr-16500	309	6	mealey	PERSON
ihlr-16500	310	1	liab.	ORG
ihlr-16500	311	1	sept. 5, 2005	DATE
ihlr-16500	311	2	23	CARDINAL
ihlr-16500	311	3	23	CARDINAL
ihlr-16500	312	1	texas	GPE
ihlr-16500	312	2	$250 million	MONEY
ihlr-16500	313	1	69	CARDINAL
ihlr-16500	313	2	texas	GPE
ihlr-16500	313	3	$250 million	MONEY
ihlr-16500	313	4	jm vioxx	ORG
ihlr-16500	313	5	68	CARDINAL
ihlr-16500	314	1	70	CARDINAL
ihlr-16500	314	2	aaron smith	PERSON
ihlr-16500	314	3	merck	ORG
ihlr-16500	314	4	merck	ORG
ihlr-16500	314	5	$253 million	MONEY
ihlr-16500	315	1	aug. 19, 2005	DATE
ihlr-16500	316	1	71	CARDINAL
ihlr-16500	316	2	texas	GPE
ihlr-16500	316	3	$250 million	MONEY
ihlr-16500	316	4	181	CARDINAL
ihlr-16500	316	5	68	CARDINAL
ihlr-16500	316	6	72	CARDINAL
ihlr-16500	316	7	new jersey	GPE
ihlr-16500	316	8	mealey	PERSON
ihlr-16500	317	1	liab.	ORG
ihlr-16500	318	1	dec. 2, 2005	DATE
ihlr-16500	318	2	29	CARDINAL
ihlr-16500	318	3	29	DATE
ihlr-16500	319	1	new jersey	GPE
ihlr-16500	320	1	73	CARDINAL
ihlr-16500	320	2	new jersey	GPE
ihlr-16500	320	3	72	DATE
ihlr-16500	321	1	74	CARDINAL
ihlr-16500	322	1	2007	DATE
ihlr-16500	322	2	129	CARDINAL
ihlr-16500	322	3	merck	ORG
ihlr-16500	322	4	more than 2,700	CARDINAL
ihlr-16500	323	1	7s	CARDINAL
ihlr-16500	324	1	76	CARDINAL
ihlr-16500	324	2	third	ORDINAL
ihlr-16500	324	3	first	ORDINAL
ihlr-16500	324	4	plunkett v. merck	PERSON
ihlr-16500	324	5	houston	GPE
ihlr-16500	324	6	texas	GPE
ihlr-16500	325	1	77	CARDINAL
ihlr-16500	325	2	plunkett	GPE
ihlr-16500	326	1	nearly two and a half days	CARDINAL
ihlr-16500	331	1	three	CARDINAL
ihlr-16500	333	1	three	CARDINAL
ihlr-16500	333	2	third	ORDINAL
ihlr-16500	333	3	merck	ORG
ihlr-16500	334	1	one	CARDINAL
ihlr-16500	335	1	first	ORDINAL
ihlr-16500	335	2	texas	GPE
ihlr-16500	336	1	second	ORDINAL
ihlr-16500	336	2	new jersey	GPE
ihlr-16500	336	3	merck	ORG
ihlr-16500	337	1	three	CARDINAL
ihlr-16500	338	1	one	CARDINAL
ihlr-16500	339	1	three	CARDINAL
ihlr-16500	339	2	merck	ORG
ihlr-16500	339	3	75 ld	MONEY
ihlr-16500	339	4	76	DATE
ihlr-16500	340	1	merck	ORG
ihlr-16500	340	2	6,400	CARDINAL
ihlr-16500	340	3	merck	ORG
ihlr-16500	340	4	merck	ORG
ihlr-16500	340	5	second	ORDINAL
ihlr-16500	340	6	nov. 10,2005	DATE
ihlr-16500	341	1	77	CARDINAL
ihlr-16500	341	2	jill federal vioxx trail	PERSON
ihlr-16500	341	3	mealey	PERSON
ihlr-16500	342	1	liab.	ORG
ihlr-16500	344	1	dec. 16, 2005	DATE
ihlr-16500	344	2	24	CARDINAL
ihlr-16500	344	3	24	DATE
ihlr-16500	344	4	hereinafter jill	ORG
ihlr-16500	345	1	79	CARDINAL
ihlr-16500	346	1	80	CARDINAL
ihlr-16500	346	2	texas	GPE
ihlr-16500	346	3	$250 million	MONEY
ihlr-16500	346	4	jill vioxx	PERSON
ihlr-16500	346	5	68	CARDINAL
ihlr-16500	346	6	new jersey	GPE
ihlr-16500	346	7	72	DATE
ihlr-16500	346	8	jill federal vioxx trail	ORG
ihlr-16500	346	9	77	CARDINAL
ihlr-16500	347	1	81	CARDINAL
ihlr-16500	349	1	130	CARDINAL
ihlr-16500	349	2	indiana	GPE
ihlr-16500	349	3	4:115	CARDINAL
ihlr-16500	349	4	the next ten years	DATE
ihlr-16500	350	1	82	CARDINAL
ihlr-16500	352	1	one	CARDINAL
ihlr-16500	353	1	tical	ORG
ihlr-16500	357	1	fda	ORG
ihlr-16500	360	1	merck	ORG
ihlr-16500	360	2	the justice department	ORG
ihlr-16500	361	1	83	CARDINAL
ihlr-16500	361	2	merck	ORG
ihlr-16500	361	3	at least three	CARDINAL
ihlr-16500	361	4	82	CARDINAL
ihlr-16500	361	5	three	CARDINAL
ihlr-16500	362	1	brooks v. merck & co. inc.	ORG
ihlr-16500	362	2	443	CARDINAL
ihlr-16500	362	3	f. supp	PERSON
ihlr-16500	363	1	2d 994	CARDINAL
ihlr-16500	364	1	2006	DATE
ihlr-16500	365	1	melton v. merck & co. inc	ORG
ihlr-16500	365	2	2006	DATE
ihlr-16500	365	3	u.s.	GPE
ihlr-16500	366	1	37376	DATE
ihlr-16500	366	2	b.d. ky	ORG
ihlr-16500	367	1	june l, 2006	DATE
ihlr-16500	367	2	salinas v. merck & co. inc.	ORG
ihlr-16500	367	3	2006	DATE
ihlr-16500	367	4	u.s.	GPE
ihlr-16500	368	1	12196	DATE
ihlr-16500	369	1	tex. mar. 7, 2006	GPE
ihlr-16500	370	1	83	CARDINAL
ihlr-16500	370	2	amy barrett	PERSON
ihlr-16500	370	3	merck	ORG
ihlr-16500	371	1	years	DATE
ihlr-16500	372	1	onune	PERSON
ihlr-16500	372	2	nov. 22, 2004	DATE
ihlr-16500	373	1	84	CARDINAL
ihlr-16500	373	2	cindi solomon & sandy	ORG
ihlr-16500	373	3	1	CARDINAL
ihlr-16500	373	4	mealey	DATE
ihlr-16500	373	5	15	CARDINAL
ihlr-16500	374	1	2007	DATE
ihlr-16500	374	2	131	CARDINAL
ihlr-16500	374	3	2005	DATE
ihlr-16500	374	4	the new england journal of medicine	ORG
ihlr-16500	374	5	three	CARDINAL
ihlr-16500	374	6	vi­ oxx	PERSON
ihlr-16500	375	1	86	CARDINAL
ihlr-16500	376	1	merck	ORG
ihlr-16500	376	2	merck	ORG
ihlr-16500	378	1	87	CARDINAL
ihlr-16500	381	1	1996	DATE
ihlr-16500	381	2	warner-lambert	ORG
ihlr-16500	381	3	fda	ORG
ihlr-16500	381	4	88	CARDINAL
ihlr-16500	381	5	warner-lambert	ORG
ihlr-16500	381	6	fda	ORG
ihlr-16500	382	1	89	CARDINAL
ihlr-16500	382	2	391	CARDINAL
ihlr-16500	383	1	90	CARDINAL
ihlr-16500	383	2	fda	ORG
ihlr-16500	383	3	warner-lambert	ORG
ihlr-16500	383	4	fda	ORG
ihlr-16500	383	5	the justice department	ORG
ihlr-16500	384	1	91	CARDINAL
ihlr-16500	385	1	warner-lambert	ORG
ihlr-16500	385	2	1995	DATE
ihlr-16500	385	3	ten million dollar	MONEY
ihlr-16500	385	4	alex berenson	PERSON
ihlr-16500	385	5	merck	ORG
ihlr-16500	385	6	n.y.	GPE
ihlr-16500	385	7	july 21, 2005	DATE
ihlr-16500	386	1	86	CARDINAL
ihlr-16500	386	2	chris rangel	PERSON
ihlr-16500	387	1	the new england journal	ORG
ihlr-16500	387	2	dec. 9, 2005	DATE
ihlr-16500	387	3	http://www.rangelmd.com/2005112/new­ england-journal	ORG
ihlr-16500	388	1	87	CARDINAL
ihlr-16500	389	1	88	CARDINAL
ihlr-16500	389	2	melissa marie bean	PERSON
ihlr-16500	389	3	2003	DATE
ihlr-16500	390	1	881,904,908	CARDINAL
ihlr-16500	390	2	2003	DATE
ihlr-16500	391	1	rezulin	PERSON
ihlr-16500	393	1	903	CARDINAL
ihlr-16500	394	1	904	CARDINAL
ihlr-16500	395	1	903	CARDINAL
ihlr-16500	395	2	91	CARDINAL
ihlr-16500	395	3	904	CARDINAL
ihlr-16500	396	1	132	CARDINAL
ihlr-16500	396	2	indiana	GPE
ihlr-16500	398	1	4:115	CARDINAL
ihlr-16500	398	2	manu­	ORG
ihlr-16500	399	1	92	CARDINAL
ihlr-16500	400	1	manu­	ORG
ihlr-16500	401	1	tum	GPE
ihlr-16500	401	2	neys	GPE
ihlr-16500	403	1	one	CARDINAL
ihlr-16500	408	1	bayer	ORG
ihlr-16500	408	2	2001	DATE
ihlr-16500	408	3	one	CARDINAL
ihlr-16500	409	1	bayer	ORG
ihlr-16500	409	2	statin coun­	PERSON
ihlr-16500	409	3	zocor	ORG
ihlr-16500	409	4	bayer	ORG
ihlr-16500	409	5	nearly one hundred	CARDINAL
ihlr-16500	409	6	muscles.95	LAW
ihlr-16500	409	7	bayer	ORG
ihlr-16500	409	8	bayer	ORG
ihlr-16500	409	9	fifty billion dollars	MONEY
ihlr-16500	409	10	bayer	ORG
ihlr-16500	410	1	first	ORDINAL
ihlr-16500	410	2	bayer	ORG
ihlr-16500	410	3	2,312	CARDINAL
ihlr-16500	410	4	$872 million	MONEY
ihlr-16500	410	5	one million dollars	MONEY
ihlr-16500	410	6	roughly 100	CARDINAL
ihlr-16500	410	7	or92	PRODUCT
ihlr-16500	411	1	93	CARDINAL
ihlr-16500	412	1	94	CARDINAL
ihlr-16500	412	2	monica langley	PERSON
ihlr-16500	412	3	bayer	ORG
ihlr-16500	413	1	wall st	PERSON
ihlr-16500	413	2	j.	PERSON
ihlr-16500	413	3	4, 2004	DATE
ihlr-16500	413	4	al	GPE
ihlr-16500	413	5	availableatbttp://webreprints.djreprints.com/1220931162452	GPE
ihlr-16500	414	1	9s	CARDINAL
ihlr-16500	417	1	2007	DATE
ihlr-16500	418	1	133	CARDINAL
ihlr-16500	418	2	nearly 9,278	CARDINAL
ihlr-16500	418	3	bayer	ORG
ihlr-16500	418	4	nearly $1.2 billion	MONEY
ihlr-16500	419	1	98	CARDINAL
ihlr-16500	419	2	bayer	ORG
ihlr-16500	420	1	bayer	ORG
ihlr-16500	420	2	2,312	CARDINAL
ihlr-16500	420	3	nearly $872 million	MONEY
ihlr-16500	421	1	99	CARDINAL
ihlr-16500	422	1	9,000	CARDINAL
ihlr-16500	422	2	mikal watts	PERSON
ihlr-16500	422	3	fifty billion	MONEY
ihlr-16500	422	4	bayer	ORG
ihlr-16500	422	5	one	CARDINAL
ihlr-16500	424	1	bayer	ORG
ihlr-16500	424	2	thousands	CARDINAL
ihlr-16500	424	3	the next decade	DATE
ihlr-16500	424	4	bayer	ORG
ihlr-16500	424	5	baycol	ORG
ihlr-16500	425	1	merck	ORG
ihlr-16500	426	1	ninth	ORDINAL
ihlr-16500	426	2	the last seven years	DATE
ihlr-16500	427	1	104	CARDINAL
ihlr-16500	428	1	100	CARDINAL
ihlr-16500	428	2	101	CARDINAL
ihlr-16500	428	3	bayer historical prices	ORG
ihlr-16500	428	4	nov. 18, 2000	DATE
ihlr-16500	428	5	jan. 4, 2003	DATE
ihlr-16500	428	6	feb. 20, 2007	DATE
ihlr-16500	429	1	2001 to 2003	DATE
ihlr-16500	429	2	bayer	ORG
ihlr-16500	429	3	approximately eighteen dollars	MONEY
ihlr-16500	430	1	102	CARDINAL
ihlr-16500	430	2	yahoo	ORG
ihlr-16500	430	3	aug. 2, 2004 to nov. 4, 2004	DATE
ihlr-16500	430	4	feb. 20, 2007	DATE
ihlr-16500	431	1	a span of three months	DATE
ihlr-16500	431	2	august 2004 to october 2004	DATE
ihlr-16500	431	3	merck	ORG
ihlr-16500	431	4	approximately sixteen dollars	MONEY
ihlr-16500	432	1	103	CARDINAL
ihlr-16500	433	1	104	CARDINAL
ihlr-16500	433	2	placitella & klein	ORG
ihlr-16500	433	3	supra	PERSON
ihlr-16500	433	4	33	CARDINAL
ihlr-16500	433	5	222	CARDINAL
ihlr-16500	434	1	134	CARDINAL
ihlr-16500	434	2	indiana health law review	ORG
ihlr-16500	434	3	4:115	CARDINAL
ihlr-16500	435	1	1999	DATE
ihlr-16500	435	2	one hundred million	CARDINAL
ihlr-16500	435	3	twenty million	CARDINAL
ihlr-16500	435	4	about $2.5 billion	MONEY
ihlr-16500	435	5	annual	DATE
ihlr-16500	436	1	105	CARDINAL
ihlr-16500	436	2	indi­ vidual plaintiff	GPE
ihlr-16500	436	3	day	DATE
ihlr-16500	436	4	merck	ORG
ihlr-16500	436	5	more than twelve dollars	MONEY
ihlr-16500	436	6	forty-five to	CARDINAL
ihlr-16500	436	7	around thirty dollars	MONEY
ihlr-16500	436	8	merck	ORG
ihlr-16500	436	9	third	ORDINAL
ihlr-16500	436	10	the months	DATE
ihlr-16500	436	11	merck	ORG
ihlr-16500	436	12	230	CARDINAL
ihlr-16500	436	13	twenty percent	PERCENT
ihlr-16500	438	1	thousands	CARDINAL
ihlr-16500	438	2	merck	ORG
ihlr-16500	438	3	sult ofvioxx's	ORG
ihlr-16500	440	1	merck	ORG
ihlr-16500	440	2	nearly 7,000	CARDINAL
ihlr-16500	441	1	merck	ORG
ihlr-16500	441	2	raymond gilmartin	PERSON
ihlr-16500	441	3	u.s.	GPE
ihlr-16500	441	4	105	CARDINAL
ihlr-16500	441	5	richard a. epstein	PERSON
ihlr-16500	441	6	celebrex	ORG
ihlr-16500	441	7	5	CARDINAL
ihlr-16500	442	1	741,741	CARDINAL
ihlr-16500	442	2	2005	DATE
ihlr-16500	443	1	106	CARDINAL
ihlr-16500	444	1	742	CARDINAL
ihlr-16500	444	2	merck	ORG
ihlr-16500	444	3	cox-2 drug vioxx	ORG
ihlr-16500	445	1	daily	DATE
ihlr-16500	445	2	may 6, 2005	DATE
ihlr-16500	447	1	107	CARDINAL
ihlr-16500	447	2	supra	PERSON
ihlr-16500	447	3	05	DATE
ihlr-16500	447	4	743	CARDINAL
ihlr-16500	447	5	aaron smith	PERSON
ihlr-16500	447	6	canadian vioxx study chal­	ORG
ihlr-16500	447	7	first few weeks	DATE
ihlr-16500	447	8	merck	ORG
ihlr-16500	447	9	may 3, 2006	DATE
ihlr-16500	447	10	108	CARDINAL
ihlr-16500	447	11	supra	PERSON
ihlr-16500	447	12	105	CARDINAL
ihlr-16500	447	13	743	CARDINAL
ihlr-16500	448	1	109	CARDINAL
ihlr-16500	448	2	d.	NORP
ihlr-16500	448	3	joseph kay	PERSON
ihlr-16500	448	4	merck	ORG
ihlr-16500	448	5	7,000	CARDINAL
ihlr-16500	448	6	dec. 2, 2005	DATE
ihlr-16500	448	7	111	ORG
ihlr-16500	448	8	phil taylor	PERSON
ihlr-16500	448	9	merck	ORG
ihlr-16500	448	10	sept. 5, 2005	DATE
ihlr-16500	448	11	135	CARDINAL
ihlr-16500	451	1	one	CARDINAL
ihlr-16500	452	1	vi	PERSON
ihlr-16500	453	1	fda	ORG
ihlr-16500	455	1	fda	ORG
ihlr-16500	455	2	60 minutes	TIME
ihlr-16500	455	3	fda	ORG
ihlr-16500	455	4	americans	NORP
ihlr-16500	455	5	market.115	ORG
ihlr-16500	456	1	fda	ORG
ihlr-16500	459	1	112	CARDINAL
ihlr-16500	459	2	greg radinsky	PERSON
ihlr-16500	459	3	2	CARDINAL
ihlr-16500	459	4	j. healml	PERSON
ihlr-16500	460	1	213	CARDINAL
ihlr-16500	460	2	2003	DATE
ihlr-16500	461	1	113	CARDINAL
ihlr-16500	461	2	alex berenson	PERSON
ihlr-16500	461	3	n.y. t1mes	GPE
ihlr-16500	461	4	nov. 14,2005	DATE
ihlr-16500	462	1	114	CARDINAL
ihlr-16500	462	2	lis	PERSON
ihlr-16500	462	3	136	CARDINAL
ihlr-16500	462	4	indiana	GPE
ihlr-16500	462	5	4:115	CARDINAL
ihlr-16500	462	6	daily	DATE
ihlr-16500	464	1	116	CARDINAL
ihlr-16500	464	2	a. drug	PERSON
ihlr-16500	465	1	117	CARDINAL
ihlr-16500	472	1	fda	ORG
ihlr-16500	474	1	tical company's	ORG
ihlr-16500	474	2	116 epstein	PERSON
ihlr-16500	474	3	supra	PERSON
ihlr-16500	474	4	105	CARDINAL
ihlr-16500	474	5	745	CARDINAL
ihlr-16500	475	1	117	CARDINAL
ihlr-16500	475	2	aaron smith	PERSON
ihlr-16500	475	3	aug. 19, 2005	DATE
ihlr-16500	476	1	lis jd	PERSON
ihlr-16500	476	2	119	CARDINAL
ihlr-16500	476	3	88	CARDINAL
ihlr-16500	476	4	2007	DATE
ihlr-16500	477	1	137	CARDINAL
ihlr-16500	477	2	fda	ORG
ihlr-16500	479	1	tical company	ORG
ihlr-16500	480	1	120	CARDINAL
ihlr-16500	480	2	manu­	ORG
ihlr-16500	481	1	121	CARDINAL
ihlr-16500	481	2	recent years	DATE
ihlr-16500	482	1	1997	DATE
ihlr-16500	482	2	1	CARDINAL
ihlr-16500	482	3	thirteen	CARDINAL
ihlr-16500	483	1	122	CARDINAL
ihlr-16500	483	2	thirteen	CARDINAL
ihlr-16500	483	3	many years	DATE
ihlr-16500	484	1	123	CARDINAL
ihlr-16500	485	1	120	CARDINAL
ihlr-16500	485	2	feb. 20, 2007	DATE
ihlr-16500	486	1	phrma	PERSON
ihlr-16500	487	1	d.	NORP
ihlr-16500	487	2	' s mis­ sion	WORK_OF_ART
ihlr-16500	489	1	121	CARDINAL
ihlr-16500	489	2	first	ORDINAL
ihlr-16500	489	3	bayer	ORG
ihlr-16500	489	4	feb. 18,2003	DATE
ihlr-16500	491	1	bayer	ORG
ihlr-16500	491	2	fda	ORG
ihlr-16500	492	1	122	CARDINAL
ihlr-16500	492	2	1997-2001	DATE
ihlr-16500	492	3	fda	ORG
ihlr-16500	492	4	jan.-feb	GPE
ihlr-16500	492	5	2002	DATE
ihlr-16500	494	1	propulsid	ORG
ihlr-16500	494	2	rezulin	PERSON
ihlr-16500	494	3	duract	GPE
ihlr-16500	494	4	pondimin	GPE
ihlr-16500	496	1	d.	NORP
ihlr-16500	496	2	138	CARDINAL
ihlr-16500	496	3	indiana heal1h law review	ORG
ihlr-16500	497	1	4:115	CARDINAL
ihlr-16500	497	2	lancet	ORG
ihlr-16500	497	3	124	CARDINAL
ihlr-16500	497	4	merck	ORG
ihlr-16500	498	1	125	CARDINAL
ihlr-16500	498	2	months	DATE
ihlr-16500	498	3	ciate	ORG
ihlr-16500	498	4	fda	ORG
ihlr-16500	498	5	david graham	PERSON
ihlr-16500	498	6	fda	ORG
ihlr-16500	499	1	126	CARDINAL
ihlr-16500	500	1	graham	PERSON
ihlr-16500	500	2	88,000	CARDINAL
ihlr-16500	500	3	139,000	CARDINAL
ihlr-16500	500	4	americans	NORP
ihlr-16500	500	5	thirty to forty percent	PERCENT
ihlr-16500	500	6	500	CARDINAL
ihlr-16500	501	1	128	CARDINAL
ihlr-16500	501	2	graham	PERSON
ihlr-16500	501	3	four years earlier	DATE
ihlr-16500	502	1	fda	ORG
ihlr-16500	503	1	merck	ORG
ihlr-16500	503	2	recent years	DATE
ihlr-16500	503	3	124	CARDINAL
ihlr-16500	503	4	lancet	ORG
ihlr-16500	503	5	1823	DATE
ihlr-16500	504	1	feb. 20, 2007	DATE
ihlr-16500	507	1	125	CARDINAL
ihlr-16500	507	2	tom armitage	PERSON
ihlr-16500	507	3	merck	ORG
ihlr-16500	507	4	2000study	CARDINAL
ihlr-16500	507	5	reuters	ORG
ihlr-16500	507	6	nov. 4, 2004	DATE
ihlr-16500	507	7	merck	ORG
ihlr-16500	507	8	2000	DATE
ihlr-16500	507	9	the british medical journal	ORG
ihlr-16500	508	1	the university of berne	ORG
ihlr-16500	508	2	of2000	PRODUCT
ihlr-16500	508	3	richard horton	PERSON
ihlr-16500	508	4	merck	ORG
ihlr-16500	508	5	fda	ORG
ihlr-16500	508	6	364	CARDINAL
ihlr-16500	508	7	1995	DATE
ihlr-16500	508	8	1995	DATE
ihlr-16500	509	1	contra	NORP
ihlr-16500	510	1	kim & alise	ORG
ihlr-16500	510	2	s. reicin	PERSON
ihlr-16500	510	3	discontinuation ofvioxx	ORG
ihlr-16500	510	4	365	CARDINAL
ihlr-16500	510	5	23,23	CARDINAL
ihlr-16500	510	6	2004	DATE
ihlr-16500	510	7	juni	DATE
ihlr-16500	510	8	horton of past vioxx meta-	ORG
ihlr-16500	511	1	126	CARDINAL
ihlr-16500	511	2	placitella & klein	ORG
ihlr-16500	511	3	supra	PERSON
ihlr-16500	511	4	33	CARDINAL
ihlr-16500	511	5	221	CARDINAL
ihlr-16500	511	6	david j. graham	PERSON
ihlr-16500	511	7	md	GPE
ihlr-16500	511	8	november 18, 2004	DATE
ihlr-16500	511	9	joseph mercola	PERSON
ihlr-16500	511	10	fda	ORG
ihlr-16500	511	11	mar. 2, 2005	DATE
ihlr-16500	511	12	http://www.mercola.com/2005/mar/2/vioxx	CARDINAL
ihlr-16500	513	1	127	CARDINAL
ihlr-16500	513	2	placitella & klein	ORG
ihlr-16500	513	3	supra	PERSON
ihlr-16500	513	4	33	CARDINAL
ihlr-16500	513	5	221	CARDINAL
ihlr-16500	513	6	12s	CARDINAL
ihlr-16500	514	1	129	CARDINAL
ihlr-16500	514	2	mike adams	PERSON
ihlr-16500	514	3	fda	ORG
ihlr-16500	514	4	fda	ORG
ihlr-16500	515	1	nov. 6, 2004	DATE
ihlr-16500	515	2	newstarget.com/002157	TIME
ihlr-16500	516	1	130	CARDINAL
ihlr-16500	517	1	2007	DATE
ihlr-16500	517	2	139	CARDINAL
ihlr-16500	518	1	2001	DATE
ihlr-16500	518	2	thirty-one	CARDINAL
ihlr-16500	519	1	131	CARDINAL
ihlr-16500	519	2	millions	CARDINAL
ihlr-16500	521	1	only a few thousand	CARDINAL
ihlr-16500	522	1	bayer	ORG
ihlr-16500	523	1	first	ORDINAL
ihlr-16500	524	1	134	CARDINAL
ihlr-16500	524	2	second	ORDINAL
ihlr-16500	524	3	thirty	CARDINAL
ihlr-16500	525	1	135	CARDINAL
ihlr-16500	526	1	bextra	ORG
ihlr-16500	527	1	137	CARDINAL
ihlr-16500	527	2	131	CARDINAL
ihlr-16500	527	3	louise mckichan	PERSON
ihlr-16500	527	4	140	CARDINAL
ihlr-16500	527	5	statin	PRODUCT
ihlr-16500	527	6	feb. 26, 2005	DATE
ihlr-16500	527	7	15:28	CARDINAL
ihlr-16500	528	1	132	CARDINAL
ihlr-16500	528	2	alex berenson	PERSON
ihlr-16500	528	3	n.y.	GPE
ihlr-16500	528	4	may 18, 2003	DATE
ihlr-16500	529	1	133	CARDINAL
ihlr-16500	530	1	ben	PERSON
ihlr-16500	530	2	sci.	ORG
ihlr-16500	531	1	news onune	PERSON
ihlr-16500	531	2	feb. 5, 2005	DATE
ihlr-16500	532	1	bayer	ORG
ihlr-16500	533	1	several thousand	CARDINAL
ihlr-16500	534	1	four	CARDINAL
ihlr-16500	535	1	graham	PERSON
ihlr-16500	535	2	bayer	ORG
ihlr-16500	536	1	135	CARDINAL
ihlr-16500	536	2	136	CARDINAL
ihlr-16500	536	3	julie appleby &	ORG
ihlr-16500	536	4	anita manning	PERSON
ihlr-16500	536	5	jan. 4, 2005	DATE
ihlr-16500	538	1	137	CARDINAL
ihlr-16500	538	2	140	CARDINAL
ihlr-16500	538	3	indiana health law review	ORG
ihlr-16500	539	1	4:115	CARDINAL
ihlr-16500	540	1	138	CARDINAL
ihlr-16500	541	1	139	CARDINAL
ihlr-16500	541	2	bextra	ORG
ihlr-16500	541	3	the cox-2 inhibitors.141 furthermore	ORG
ihlr-16500	542	1	fda	ORG
ihlr-16500	543	1	138	CARDINAL
ihlr-16500	544	1	oct. 1, 2004	DATE
ihlr-16500	545	1	139	CARDINAL
ihlr-16500	545	2	138	CARDINAL
ihlr-16500	545	3	140	CARDINAL
ihlr-16500	545	4	nsaids	ORG
ihlr-16500	545	5	3, 2006	DATE
ihlr-16500	546	1	nsaids	ORG
ihlr-16500	547	1	http://www.mayoclinic.com/health/drug-information/dr202743	PERSON
ihlr-16500	547	2	feb. 24, 2007	DATE
ihlr-16500	549	1	nsaids	ORG
ihlr-16500	550	1	141	CARDINAL
ihlr-16500	550	2	138	CARDINAL
ihlr-16500	551	1	142	CARDINAL
ihlr-16500	551	2	mar. 3, 2005	DATE
ihlr-16500	553	1	the united states food and drug	ORG
ihlr-16500	553	2	fda	ORG
ihlr-16500	554	1	d.	NORP
ihlr-16500	554	2	fda	ORG
ihlr-16500	554	3	1.4 million	CARDINAL
ihlr-16500	554	4	1,000,000	CARDINAL
ihlr-16500	554	5	400,000	CARDINAL
ihlr-16500	554	6	naproxen	ORG
ihlr-16500	554	7	40,000	CARDINAL
ihlr-16500	554	8	27,000	CARDINAL
ihlr-16500	555	1	1.4 million	CARDINAL
ihlr-16500	555	2	8,1 00	DATE
ihlr-16500	557	1	1.6x	CARDINAL
ihlr-16500	557	2	1%	PERCENT
ihlr-16500	558	1	california	GPE
ihlr-16500	558	2	1000	CARDINAL
ihlr-16500	558	3	6	CARDINAL
ihlr-16500	559	1	1000	CARDINAL
ihlr-16500	559	2	10	CARDINAL
ihlr-16500	563	1	143	CARDINAL
ihlr-16500	563	2	fda	ORG
ihlr-16500	563	3	feb. 28, 2005	DATE
ihlr-16500	563	4	http://www .newstarget.comf005033.html	GPE
ihlr-16500	563	5	mealey	PERSON
ihlr-16500	563	6	artiiritis	PRODUCT
ihlr-16500	563	7	feb. 1, 2005	DATE
ihlr-16500	563	8	8	CARDINAL
ihlr-16500	563	9	11	DATE
ihlr-16500	564	1	fda	ORG
ihlr-16500	564	2	celebrex	ORG
ihlr-16500	564	3	bextra	ORG
ihlr-16500	565	1	thirty-two expertsconvenedbythefda	DATE
ihlr-16500	565	2	17-15 onfeb.18	TIME
ihlr-16500	565	3	2005	DATE
ihlr-16500	566	1	31	CARDINAL
ihlr-16500	566	2	17	CARDINAL
ihlr-16500	566	3	two	CARDINAL
ihlr-16500	567	1	vioxx	PERSON
ihlr-16500	567	2	supra	PERSON
ihlr-16500	568	1	2007	DATE
ihlr-16500	569	1	141	CARDINAL
ihlr-16500	570	1	the 1950s	DATE
ihlr-16500	570	2	george merck	PERSON
ihlr-16500	572	1	145	CARDINAL
ihlr-16500	572	2	recent months	DATE
ihlr-16500	572	3	years	DATE
ihlr-16500	574	1	first	ORDINAL
ihlr-16500	582	1	com144	NORP
ihlr-16500	582	2	143	CARDINAL
ihlr-16500	582	3	145	CARDINAL
ihlr-16500	583	1	raymond v. gilmartin	PERSON
ihlr-16500	584	1	merck & co. inc.	ORG
ihlr-16500	584	2	raymond v. gilmartin	PERSON
ihlr-16500	584	3	merck & co., inc.	ORG
ihlr-16500	585	1	town hall	ORG
ihlr-16500	585	2	los angeles	GPE
ihlr-16500	585	3	july 29, 2004	DATE
ihlr-16500	586	1	146	CARDINAL
ihlr-16500	586	2	3	CARDINAL
ihlr-16500	586	3	mzs­	PERSON
ihlr-16500	586	4	mealey	PERSON
ihlr-16500	586	5	dec. 1, 2005	DATE
ihlr-16500	586	6	5	CARDINAL
ihlr-16500	586	7	6	CARDINAL
ihlr-16500	586	8	142	CARDINAL
ihlr-16500	587	1	4:115	CARDINAL
ihlr-16500	588	1	a.	PERSON
ihlr-16500	590	1	fda	ORG
ihlr-16500	591	1	years	DATE
ihlr-16500	591	2	millions of dollars	MONEY
ihlr-16500	594	1	years	DATE
ihlr-16500	598	1	many years	DATE
ihlr-16500	599	1	149	CARDINAL
ihlr-16500	599	2	147	CARDINAL
ihlr-16500	600	1	21	CARDINAL
ihlr-16500	601	1	201.56	CARDINAL
ihlr-16500	601	2	201.57	CARDINAL
ihlr-16500	601	3	2006	DATE
ihlr-16500	603	1	201.57	CARDINAL
ihlr-16500	605	1	feb. 24, 2007	DATE
ihlr-16500	606	1	148	CARDINAL
ihlr-16500	607	1	half	CARDINAL
ihlr-16500	607	2	http:/lwww.answers.com	ORG
ihlr-16500	607	3	feb. 24, 2007	DATE
ihlr-16500	608	1	half	CARDINAL
ihlr-16500	608	2	half	CARDINAL
ihlr-16500	608	3	• •	EVENT
ihlr-16500	609	1	149	CARDINAL
ihlr-16500	609	2	julienne k. kirk &	PERSON
ihlr-16500	609	3	john g. spangler	PERSON
ihlr-16500	610	1	nov. 1, 1996	DATE
ihlr-16500	613	1	18890140	DATE
ihlr-16500	614	1	ten years	DATE
ihlr-16500	616	1	2007	DATE
ihlr-16500	616	2	143	CARDINAL
ihlr-16500	618	1	one	CARDINAL
ihlr-16500	619	1	the pharmaceuti­ cal company	ORG
ihlr-16500	621	1	fda	ORG
ihlr-16500	622	1	fda	ORG
ihlr-16500	623	1	fda	ORG
ihlr-16500	623	2	fda	ORG
ihlr-16500	623	3	u.s.	GPE
ihlr-16500	624	1	david gra­	PERSON
ihlr-16500	624	2	fda	ORG
ihlr-16500	624	3	american	NORP
ihlr-16500	624	4	thousands	CARDINAL
ihlr-16500	624	5	americans	NORP
ihlr-16500	624	6	fda	ORG
ihlr-16500	624	7	u.s.	GPE
ihlr-16500	624	8	150	CARDINAL
ihlr-16500	624	9	risa l. lieberwitz	PERSON
ihlr-16500	625	1	38	CARDINAL
ihlr-16500	625	2	akron l. rev	PERSON
ihlr-16500	625	3	759	CARDINAL
ihlr-16500	625	4	768	CARDINAL
ihlr-16500	625	5	2005	DATE
ihlr-16500	625	6	lisa richwine	PERSON
ihlr-16500	625	7	fda	ORG
ihlr-16500	625	8	reuters	ORG
ihlr-16500	625	9	nov. 18, 2004	DATE
ihlr-16500	625	10	athttp://www.lexisnexis.com	ORG
ihlr-16500	626	1	151	CARDINAL
ihlr-16500	626	2	150	CARDINAL
ihlr-16500	626	3	768	CARDINAL
ihlr-16500	627	1	the vioxx house committee	ORG
ihlr-16500	627	2	minnesota	GPE
ihlr-16500	627	3	gil gutknecht	PERSON
ihlr-16500	627	4	fda	ORG
ihlr-16500	628	1	fda	ORG
ihlr-16500	629	1	bernadette tansey	PERSON
ihlr-16500	629	2	s. f. chronicle	PERSON
ihlr-16500	629	3	6, 2005	DATE
ihlr-16500	629	4	152	CARDINAL
ihlr-16500	633	1	16-17	CARDINAL
ihlr-16500	634	1	com­ merce	PERSON
ihlr-16500	635	1	tauzin	ORG
ihlr-16500	635	2	the committee on energy and commerce	ORG
ihlr-16500	636	1	144	CARDINAL
ihlr-16500	637	1	4:115	CARDINAL
ihlr-16500	638	1	fda	ORG
ihlr-16500	643	1	53	CARDINAL
ihlr-16500	643	2	1	CARDINAL
ihlr-16500	643	3	merck	ORG
ihlr-16500	643	4	fda	ORG
ihlr-16500	643	5	the years	DATE
ihlr-16500	643	6	half	CARDINAL
ihlr-16500	643	7	the united states	GPE
ihlr-16500	644	1	82-87	CARDINAL
ihlr-16500	645	1	meyers	PERSON
ihlr-16500	646	1	154	CARDINAL
ihlr-16500	646	2	151	CARDINAL
ihlr-16500	647	1	iss	PERSON
ihlr-16500	647	2	d.	NORP
ihlr-16500	647	3	henry waxman	PERSON
ihlr-16500	647	4	democrat	NORP
ihlr-16500	647	5	los angeles	GPE
ihlr-16500	647	6	california	GPE
ihlr-16500	647	7	the house government reform committee	ORG
ihlr-16500	647	8	$2 billion	MONEY
ihlr-16500	648	1	d.	NORP
ihlr-16500	648	2	waxman	PERSON
ihlr-16500	648	3	20,000	CARDINAL
ihlr-16500	648	4	millions	CARDINAL
ihlr-16500	650	1	eight	CARDINAL
ihlr-16500	650	2	eleven	CARDINAL
ihlr-16500	653	1	peters	PERSON
ihlr-16500	654	1	kim	PERSON
ihlr-16500	654	2	merck research laboratories	ORG
ihlr-16500	654	3	oct. 13, 2004	DATE
ihlr-16500	654	4	2007	DATE
ihlr-16500	654	5	145	CARDINAL
ihlr-16500	655	1	1 8	CARDINAL
ihlr-16500	656	1	fda	ORG
ihlr-16500	656	2	merck	ORG
ihlr-16500	657	1	159	CARDINAL
ihlr-16500	657	2	d.	NORP
ihlr-16500	659	1	fda	ORG
ihlr-16500	664	1	viti	PERSON
ihlr-16500	666	1	first	ORDINAL
ihlr-16500	668	1	4,000	CARDINAL
ihlr-16500	668	2	fifty milligrams.160	CARDINAL
ihlr-16500	668	3	12.5	CARDINAL
ihlr-16500	668	4	25	CARDINAL
ihlr-16500	669	1	0	CARDINAL
ihlr-16500	670	1	13	CARDINAL
ihlr-16500	672	1	158	CARDINAL
ihlr-16500	672	2	151	CARDINAL
ihlr-16500	672	3	159	CARDINAL
ihlr-16500	673	1	thomas w. abrams	PERSON
ihlr-16500	673	2	dir	GPE
ihlr-16500	673	3	u.s.	GPE
ihlr-16500	673	4	dep't health & human	ORG
ihlr-16500	673	5	raymond v. gilmartin	PERSON
ihlr-16500	673	6	ofmerck & co. inc.	ORG
ihlr-16500	674	1	sept. 17, 2001	DATE
ihlr-16500	675	1	161	CARDINAL
ihlr-16500	676	1	feb. 24, 2007	DATE
ihlr-16500	677	1	146	CARDINAL
ihlr-16500	677	2	indiana health law review	ORG
ihlr-16500	677	3	4:115	CARDINAL
ihlr-16500	677	4	several months	DATE
ihlr-16500	677	5	fda	ORG
ihlr-16500	677	6	thirty-two	CARDINAL
ihlr-16500	677	7	s. 163 a.	PERSON
ihlr-16500	677	8	one	CARDINAL
ihlr-16500	677	9	u.s.	GPE
ihlr-16500	678	1	2000	DATE
ihlr-16500	678	2	glaxo	ORG
ihlr-16500	678	3	millions	CARDINAL
ihlr-16500	678	4	americans	NORP
ihlr-16500	678	5	illness.164 just nine months	DATE
ihlr-16500	678	6	fda	ORG
ihlr-16500	678	7	seven	CARDINAL
ihlr-16500	678	8	fda	ORG
ihlr-16500	678	9	glaxo	ORG
ihlr-16500	678	10	u.s.	GPE
ihlr-16500	678	11	fewer than 5%	PERCENT
ihlr-16500	681	1	fda	ORG
ihlr-16500	682	1	fda	ORG
ihlr-16500	683	1	162	CARDINAL
ihlr-16500	683	2	143	CARDINAL
ihlr-16500	686	1	fda	ORG
ihlr-16500	687	1	163	CARDINAL
ihlr-16500	688	1	164	CARDINAL
ihlr-16500	688	2	today, june 7, 2002	DATE
ihlr-16500	689	1	165	CARDINAL
ihlr-16500	690	1	166	CARDINAL
ihlr-16500	691	1	167	CARDINAL
ihlr-16500	692	1	2007	DATE
ihlr-16500	693	1	147	CARDINAL
ihlr-16500	694	1	millions of dollars	MONEY
ihlr-16500	695	1	first	ORDINAL
ihlr-16500	695	2	first	ORDINAL
ihlr-16500	696	1	69	CARDINAL
ihlr-16500	698	1	fda	ORG
ihlr-16500	699	1	fda	ORG
ihlr-16500	699	2	fda	ORG
ihlr-16500	700	1	171	CARDINAL
ihlr-16500	701	1	phrma	ORG
ihlr-16500	701	2	alan f. holmer	PERSON
ihlr-16500	701	3	more than $30 billion	MONEY
ihlr-16500	701	4	annually	DATE
ihlr-16500	702	1	the 2002 year	DATE
ihlr-16500	702	2	about eighty percent	PERCENT
ihlr-16500	702	3	about twenty percent	PERCENT
ihlr-16500	702	4	168	CARDINAL
ihlr-16500	702	5	36	CARDINAL
ihlr-16500	702	6	w. res	PERSON
ihlr-16500	702	7	1058, 1082	DATE
ihlr-16500	702	8	1986	DATE
ihlr-16500	703	1	169	CARDINAL
ihlr-16500	703	2	170	CARDINAL
ihlr-16500	703	3	373	CARDINAL
ihlr-16500	703	4	2004	DATE
ihlr-16500	704	1	171	CARDINAL
ihlr-16500	704	2	matthew harper	PERSON
ihlr-16500	704	3	david graham	PERSON
ihlr-16500	704	4	aug. 19, 2005	DATE
ihlr-16500	705	1	148	CARDINAL
ihlr-16500	705	2	indiana	GPE
ihlr-16500	707	1	4:115	CARDINAL
ihlr-16500	708	1	172	CARDINAL
ihlr-16500	709	1	fda	ORG
ihlr-16500	709	2	more than 10,000	CARDINAL
ihlr-16500	712	1	both united states	GPE
ihlr-16500	714	1	millions of dollars	MONEY
ihlr-16500	718	1	today	DATE
ihlr-16500	722	1	the united states	GPE
ihlr-16500	723	1	fda	ORG
ihlr-16500	724	1	174	CARDINAL
ihlr-16500	724	2	172	CARDINAL
ihlr-16500	724	3	12	CARDINAL
ihlr-16500	724	4	235	CARDINAL
ihlr-16500	724	5	173	CARDINAL
ihlr-16500	724	6	michelle meadows	PERSON
ihlr-16500	724	7	fda	ORG
ihlr-16500	724	8	jan.-feb	GPE
ihlr-16500	724	9	2002	DATE
ihlr-16500	724	10	11	CARDINAL
ihlr-16500	724	11	11	CARDINAL
ihlr-16500	726	1	174	CARDINAL
ihlr-16500	726	2	eric j. topol	PERSON
ihlr-16500	726	3	merck	ORG
ihlr-16500	726	4	fda	ORG
ihlr-16500	726	5	2007	DATE
ihlr-16500	726	6	149	CARDINAL
ihlr-16500	732	1	millions of dollars	MONEY
ihlr-16500	732	2	ized	ORG
ihlr-16500	733	1	175	CARDINAL
ihlr-16500	740	1	fda	ORG
ihlr-16500	743	1	first	ORDINAL
ihlr-16500	743	2	176	CARDINAL
ihlr-16500	744	1	one	CARDINAL
ihlr-16500	744	2	351	CARDINAL
ihlr-16500	745	1	j. med.	PERSON
ihlr-16500	745	2	1707	CARDINAL
ihlr-16500	745	3	1707-09	CARDINAL
ihlr-16500	745	4	thomas l. friedman	PERSON
ihlr-16500	745	5	252	CARDINAL
ihlr-16500	745	6	2006	DATE
ihlr-16500	746	1	175	CARDINAL
ihlr-16500	747	1	176	CARDINAL
ihlr-16500	747	2	barry werth	PERSON
ihlr-16500	747	3	billion dollar	MONEY
ihlr-16500	747	4	one	CARDINAL
ihlr-16500	747	5	1994	DATE
ihlr-16500	748	1	150	CARDINAL
ihlr-16500	748	2	indiana health law review	ORG
ihlr-16500	749	1	4:115	CARDINAL